Diversion Control Homepage Diversion Control Homepage Privacy Policy Contact Us What's New Hot Items Site Map Search Diversion SiteDEA Diversion Control Program Logo and Banner

Publications > Manuals > NTP Best Practice Guideline > Receiving Medication > Identification of Discrepancy/Damage to a Shipment

Receiving Medication


Identification of Discrepancy/Damage to a Shipment

Procedures to be followed when a discrepancy or damage is found by the designated NTP staff at the time of delivery include the following:

  • When all or part of a shipment disappears, or never reaches its intended destination, the supplier is responsible for reporting any in-transit losses of controlled substances to DEA. An NTP is responsible for reporting any losses of controlled substances after a designated staff member has signed for and taken custody of a shipment. [21 CFR 1301.74(c)].

See the section entitled "Reporting Thefts and Losses of Controlled Substance Medication," in Part 6, "Recordkeeping," which discusses the filing of DEA Form-106, "Report of Theft or Loss of Controlled Substances."

  • If, when checking a shipment at the time of receipt, the designated staff member receiving a shipment determines that there is a discrepancy between the amount of medication received and the amount ordered (i.e., a discrepancy that has not been explained by the supplier on the invoice included with the delivered order), the staff member should contact the supplier immediately for further instructions.
     
  • When the designated staff member receiving a shipment determines that there has been damage to the medication, the staff member should contact the supplier immediately.
     
  • The supplier should contact the appropriate DEA office immediately after being notified by the NTP of a discrepancy or damage found in a shipment.
     
  • The supplier should contact the NTP to advise the program of the final determination regarding the discrepancy or damage.
     
  • The NTP should document the discrepancy or damage to the shipment, related actions taken, and the final determination, which should be attached to Copy 3 of the relevant order form.

Previous Page | Back to Top | Next Page


Registration Support  
Toll Free Number: 1-800-882-9539

ARCOS
| Career Opportunities | Chemical Program | Controlled Substance Schedules | Drugs and Chemicals of Concern  
Electronic Commerce Initiatives |  | Federal Register Notices | Import Export | Links | Meetings and Events | NFLIS
Offices & Directories | On-Line Forms & Applications | Program DescriptionPublications | Questions & Answers | Quotas  
  Reports Required by 21 CFR | Title 21 Regulations & Codified CSA
   Contact Us | HomeHot Items | Site Map | Search | What's New